Rifampicin Clinical Trials
5 recruitingDrug
Phase 23Phase 32
Showing 1–5 of 5 trials
Recruiting
Phase 2
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)315 enrolled28 locationsNCT06192160
Recruiting
Phase 2
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
Tuberculous Meningitis
National Institute of Allergy and Infectious Diseases (NIAID)330 enrolled18 locationsNCT05383742
Recruiting
Phase 3
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
Lung InfectionMAC Lung Disease
Centre Hospitalier Universitaire, Amiens424 enrolled3 locationsNCT03236987
Recruiting
Phase 2
PanACEA - STEP2C -01
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher390 enrolled10 locationsNCT05807399
Recruiting
Phase 3
Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR
Prosthetic Infection
Tourcoing Hospital436 enrolled30 locationsNCT04672525